US 8404869
Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
granted A61PA61P1/16A61P27/02
Quick answer
US patent 8404869 (Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome) held by MAZENCE INC. expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MAZENCE INC.
- Grant date
- Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/16, A61P27/02, A61P29/00, A61P3/00